Abstract
Protein kinases are critical modulators of a variety of intracellular and extracellular signal transduction pathways, and abnormal phosphorylation events can contribute to disease progression in a variety of diseases. As a result, protein kinases have emerged as important new drug targets for small molecule therapeutics. The mitogen-activated protein kinase (MAPK) signaling pathway transmits signals from the cell membrane to the nucleus in response to a variety of different stimuli. Because this pathway controls a broad spectrum of cellular processes, including growth, inflammation, and stress responses, it is accepted as a therapeutic target for cancer and peripheral inflammatory disorders. There is also increasing evidence that MAPK is an important regulator of ischemic and hemorrhagic cerebral vascular disease, raising the possibility that it might be a drug discovery target for stroke. In this review, we discuss the MAPK signaling pathway in association with its activation in stroke-induced brain injury.
Similar content being viewed by others
References
Ahnstedt H, Säveland H, Nilsson O, Edvinsson L (2011) Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway. BMC Neurosci 12:5
Ansar S, Maddahi A, Edvinsson L (2011) Inhibition of cerebrovascular raf activation attenuates cerebral blood flow and prevents upregulation of contractile receptors after subarachnoid hemorrhage. BMC Neurosci 12:107
Aronowski J, Zhao X (2011) Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke 42(6):1781–1786
Babu R, Bagley JH, Di C, Friedman AH, Adamson C (2012) Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention. Neurosurg Focus 32(4):E8
Bas DB, Abdelmoaty S, Sandor K, Codeluppi S, Fitzsimmons B, Steinauer J, Hua XY, Yaksh TL, Svensson CI (2015) Spinal release of tumour necrosis factor activates c-Jun N-terminal kinase and mediates inflammation-induced hypersensitivity. Eur J Pain 19(2):260–270
Beg SA, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI (2006) ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ETB and 5-HT1B receptor upregulation after subarachnoid hemorrhage in rat. J Cereb Blood Flow Metab 26(6):846–856
Borders AS, de Almeida L, Van Eldik LJ, Watterson DM (2008) The p38αmitogen-actibated protein kinase as a central nervous system drug discovery target. BMC Neurosci 9(Suppl 2):S12
Cai Y, Cho GS, Ju C, Wang SL, Ryu JH, Shin CY, Kim HS, Nam KW, Jalin AMAA, Sun W, Choi IY, Kim WK (2011) Activated microglia are less vulnerable to hemin toxicity due to nitric oxide-dependent inhibition of JNK and p38 MAPK activation. J Immunol 187(3):1314–1321
Cardoso FL, Brites D, Brito MA (2010) Looking at the blood–brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev 64(2):328–363
Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75(1):50–83
Cheng YL, Choi Y, Seow WL, Manzanero S, Sobey CG, Jo DG, Arumugam TV (2014) Evidence that neuronal notch-1 promotes JNK/c-Jun activation and cell death following ischemic stress. Brain Res 1586:193–202
Choudhury G, Ryou MG, Poteet E, Wen Y, He R, Sun F, Yuan F, Jin K, Yang SH (2014) Involvement of p38 MAPK in reactive astrogliosis induced by ischemic stroke. Brain Res 1551:45–58
Culbert AA, Skaper SD, Howlett DR, Evans NA, Facci L, Soden PE, Seymour ZM, Guillot F, Gaestel M, Richardson JC (2006) MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. J Biol Chem 281(33):23658–23667
Edelmayer RM, Brederson JD, Jarvis MF, Bitner RS (2014) Biochemical and pharmacological assessment of MAP-kinase signaling along pain pathways in experimental rodent models: a potential tool for the discovery of novel antinociceptive therapeutics. Biochem Pharmacol 87(3):390–398
Fang H, Wang PF, Zhou Y, Wang YC, Yang QW (2013) Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury. J Neuroinflammation 10:27
Fischer S, Wiesnet M, Renz D, Schaper W (2005) H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur J Cell Biol 84(7):687–697
Fujimoto S, Katsuki H, Kume T, Akaike A (2006) Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures. Neurobiol Dis 22(1):130–142
Fujimoto S, Katsuki H, Ohnishi M, Takagi M, Kume T, Akaike A (2007) Thrombin induces striatal neurotoxicity depending on mitogen-activated protein kinase pathways in vivo. Neuroscience 144(2):694–701
Gladbach A, van Eersel J, Bi M, Ke YD, Ittner LM (2014) ERK inhibition with PD184161 mitigates brain damage in a mouse model of stroke. J Neural Transm 121(5):543–547
González-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778(3):729–756
Gram M, Sveinsdottir S, Ruscher K, Hansson SR, Cinthio M, Åkerström B, Ley D (2013) Hemoglobin induces inflammation after preterm intraventricular hemorrhage by methemoglobin formation. J Neuroinflammation 10:100
Gurgis FM, Ziaziaris W, Munoz L (2014) Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting. Mol Pharmacol 85(2):345–356
He Q, Bao L, Zimering J, Zan K, Zhang Z, Shi H, Zu J, Yang X, Hua F, Ye X, Cui G (2015) The protective role of (−)-epigallocatechin-3-gallate in thrombin-induced neuronal cell apoptosis and JNK-MAPK activation. Neuroreport 26(7):416–423
Huang L, Wan J, Chen Y, Wang ZW, Hui L, Li Y, Xu DW, Zhou WK (2013) Inhibitory effects of p38 inhibitor against mitochondrial dysfunction in the early brain injury after subarachnoid hemorrhage in mice. Brain Res 1517:133–140
Kaminska B, Gozdz A, Zawadzka M, Miklaszewska A, Lipko M (2009) MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat Rec 292(12):1902–1913
Kant S, Swat W, Zhang S, Zhang ZY, Neel BG, Flavell RA, Davis RJ (2011) TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. Genes Dev 25(19):2069–2078
Keep RF, Zhou N, Xiang J, Andjelkovic AV, Hua Y, Xi G (2014) Vascular disruption and blood–brain barrier dysfunction in intracerebral hemorrhage. Fluids Barriers CNS 11:18
Kleinig TJ, Vink R (2009) Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options. Curr Opin Neurol 22(3):294–301
Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-αbiosynthesis. Nat Cell Biol 1(2):94–97
Koul HK, Pal M, Koul S (2013) Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer 4(9–10):342–359
Kovalska M, Kovalska L, Pavlikova M, Janickova M, Mikuskova K, Adamkov M, Kaplan P, Tatarkova Z, Lehotsky J (2012) Intracellular signaling MAPK pathway after cerebral ischemia-reperfusion injury. Neurochem Res 37(7):1568–1577
Krementsov DN, Thornton TM, Teuscher C, Rincon M (2013) The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models. Mol Cell Biol 33(19):3728–3734
Kyriakis JM, Avruch J (2012) Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 92(2):689–737
Lei YY, Wang WJ, Mei JH, Wang CL (2014) Mitogen-activated protein kinase signal transduction in solid tumors. Asian Pac J Cancer Prev 15(20):8539–8548
Lin S, Yin Q, Zhong Q, Lv FL, Zhou Y, Li JQ, Wang JZ, Su BY, Yang QW (2012) Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation 9:46
Liu NQ, Lossinsky AS, Popik W, Li X, Gujuluva C, Kriederman B, Roberts J, Pushkarsky T, Bukrinsky M, Witte M, Weinand M, Fiala M (2002) Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol 76(13):6689–6700
Ma Q, Huang B, Khatibi N, Rolland W II, Suzuki H, Zhang JH, Tang J (2011) PDGFR-⍺ inhibition preserves blood–brain barrier after intracerebral hemorrhage. Ann Neurol 70(6):920–931
Maddahi A, Ansar S, Chen Q, Edvinsson L (2011a) Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model. J Cereb Blood Flow Metab 31(1):144–154
Maddahi A, Edvinsson L (2010) Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J Neuroinflammation 7:14
Maddahi A, Kruse LS, Chen QW, Edvinsson L (2011b) The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat. J Neuroinflammation 8(1):107
Maddahi A, Povlsen GK, Edvinsson L (2012) Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway. J Neuroinflammation 9:274
Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR (2001) Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21(19):6461–6469
Matter K, Balda MS (2003) Signalling to and from tight junctions. Nat Rev Mol Cell Biol 4(3):225–236
Miller F, Fenart L, Landry V, Coisne C, Cecchelli R, Dehouck MP, Scherrer VB (2005) The MAP kinase pathway mediates transcytosis induced by TNF-αin an in vitro blood–brain barrier model. Eur J Neurosci 22(4):835–844
Mracsko E, Veltkamp R (2014) Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci 8:388
Munshi A, Ramesh R (2013) Mitogen-activated protein kinases and their role in radiation response. Genes Cancer 4(9–10):401–408
Nito C, Kamada H, Endo H, Niizuma K, Myer DJ, Chan PH (2008) Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood–brain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 28(10):1686–1696
Ohnishi M, Katsuki H, Fujimoto S, Takagi M, Kume T, Akaike A (2007) Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury. Exp Neurol 206(1):43–52
Ohnishi M, Katsuki H, Izumi Y, Kume T, Takada-Takatori Y, Akaike A (2010) Mitogen-activated protein kinases support survival of activated microglia that mediate thrombin-induced striatal injury in organotypic slice culture. J Neurosci Res 88(10):2155–2164
Pan YX, Chen KF, Lin YX, Wu W, Zhou XM, Zhang XS, Zhang X, Shi JX (2013) Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-α. J Clin Neurosci 20(5):726–730
Piao CS, Kim JB, Han PL, Lee JK (2003) Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult. J Neurosci Res 73(4):537–544
Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26(22):3291–3310
Ruhul Amin AR, Senga T, Oo ML, Thant AA, Hamaguchi M (2003) Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and erk. Genes Cells 8(6):515–523
Sabio G, Davis RJ (2014) TNF and MAP kinase signalling pathways. Semin Immunol 26(3):237–245
Vikman P, Ansar S, Henriksson M, Stenman E, Edvinsson L (2007) Cerebral ischemia induces transcription of inflammatory and extracellular-matrix-related genes in rat cerebral arteries. Exp Brain Res 183(4):499–510
Wang J, Doré S (2007) Inflammation after intracerebral hemorrhage. Cereb Blood Flow Metab 27:894–908
Wang X, Xu L, Wang H, Young PR, Gaestel M, Feuerstein GZ (2002) Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice. J Biol Chem 277(46):43968–43972
Wang YC, Wang PF, Fang H, Chen J, Xiong XY, Yang QW (2013) Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury. Stroke 44(9):2545–2552
Wang YC, Zhou Y, Fang H, Lin S, Wang PF, Xiong RP, Chen J, Xiong XY, Lv FL, Liang QL, Yang QW (2014) Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage. Ann Neurol 75(6):876–889
Wang ZQ, Wu DC, Huang FP, Yang GY (2004) Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia. Brain Res 996(1):55–66
Wu B, Ma Q, Khatibi N, Chen W, Sozen T, Cheng Q, Tang J (2010) Ac-YVAD-CMK decreases blood–brain barrier degradation by inhibiting caspase-1 activation of interleukin-1βin intracerebral hemorrhage mouse model. Transl Stroke Res 1(1):57–64
Wu CY, Hsieh HL, Jou MJ, Yang CM (2004) Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1β-induced marix metalloproteinase-9 expression in rat brain astrocytes. J Neurochem 90(6):1477–1488
Wu Y, Chakrabarti S (2015) ERK5 mediated signalling in diabetic retinopathy. Med Hypothesis Discov Innov Ophthalmol 4:17–26
Yang Y, Kim SC, Yu T, Yi TY, Rhee MH, Sung GH, Yoo BC, Cho JY (2014) Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses. Mediat Inflamm 2014:352371
Zhang BF, Song JN, Ma XD, Zhao YL, Liu ZW, Sun P, Li DD, Pang HG, Huang TQ (2015) Etanercept alleviates early brain injury following experimental subarachnoid hemorrhage and the possible role of tumor necrosis factor-α and c-Jun N-terminal kinase pathway. Neurochem Res 40(3):591–599
Zhang X, Zhao XD, Shi JX, Yin HX (2011) Inhibition of the p38 mitogen-activated protein kinase (MAPK) pathway attenuates cerebral vasospasm following experimental subarachnoid hemorrhage in rabbits. Ann Clin Lab Sci 41(3):244–250
Zhou Y, Wang Y, Wang J, Stetler R, Yang QW (2014) Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol 115:25–44
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict Interests
The authors declare no potential conflicts of interests.
Rights and permissions
About this article
Cite this article
Sun, J., Nan, G. The Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway as a Discovery Target in Stroke. J Mol Neurosci 59, 90–98 (2016). https://doi.org/10.1007/s12031-016-0717-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-016-0717-8